DDrare: Database of Drug Development for Rare Diseases

278. 巨大リンパ管奇形（頚部顔面病変）
［臨床試験数：19，薬物数：23（DrugBank：7），標的遺伝子数：5，標的パスウェイ数：62］

Searched query = "Huge lymphatic malformation with cervicofacial lesion", "Huge lymphatic malformation", "Lymphatic malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Bleomycin; Device: MRI; Indocyanine green; L04AA10; OK432; Picibanil; Propranolol; RAPAMUNE; Rapamune; Rapamycin; Rapamycin dosage; SIROLIMUS; Selenium; Sildenafil; Sildenafil 20 mg tablets; Sirolimus; Sirolimus 0,1% crème; Sirolimus 1mg/mL; Sirolimus Oral Liquid Product 1mg/mL; Topical 0.1% Sirolimus; Topical Vehicle; VT30; Water

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01212965 (ClinicalTrials.gov)	September 2010	24/9/2010	Selenium in the Treatment of Complicated Lymphatic Malformations	Pilot Clinical Trial to Estimate the Safety and Efficacy of Selenium in the Treatment of Complicated Lymphatic Malformations in Adolescents and Young Adults	Lymphatic Malformations	Drug: Selenium	Medical College of Wisconsin	NULL	Terminated	14 Years	30 Years	Both	5	Phase 1	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01212965
(ClinicalTrials.gov)

September 2010

24/9/2010

Selenium in the Treatment of Complicated Lymphatic Malformations

Pilot Clinical Trial to Estimate the Safety and Efficacy of Selenium in the Treatment of Complicated Lymphatic Malformations in Adolescents and Young Adults

Lymphatic Malformations

Drug: Selenium

Medical College of Wisconsin

NULL

Terminated

14 Years

30 Years

Both

Phase 1

United States